comparemela.com

Latest Breaking News On - Soleno therapeutics inc - Page 7 : comparemela.com

CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Soleno Therapeutics (NASDAQ:SLNO) Trading Up 5 6%

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) were up 5.6% on Tuesday . The company traded as high as $44.06 and last traded at $44.00. Approximately 97,613 shares traded hands during trading, a decline of 68% from the average daily volume of 301,848 shares. The stock had previously closed at $41.67. Wall […]

Soleno Therapeutics (NASDAQ:SLNO) Stock Price Up 5 6%

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report)’s share price shot up 5.6% during trading on Tuesday . The stock traded as high as $44.06 and last traded at $44.00. 97,613 shares changed hands during mid-day trading, a decline of 68% from the average session volume of 301,848 shares. The stock had previously closed at […]

Vivani Medical (NASDAQ:VANI) versus Soleno Therapeutics (NASDAQ:SLNO) Financial Review

Vivani Medical (NASDAQ:VANI – Get Free Report) and Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Profitability This table compares Vivani Medical and […]

Soleno Therapeutics (NASDAQ:SLNO) versus Vivani Medical (NASDAQ:VANI) Head to Head Analysis

Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) and Vivani Medical (NASDAQ:VANI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Analyst Recommendations This is a summary of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.